Is procalcitonin a marker of invasive bacterial infection in acute sickle-cell vaso-occlusive crisis?

被引:14
作者
Stojanovic, K. Stankovic [1 ]
Steichen, O. [1 ,2 ]
Lionnet, F. [1 ]
Bachmeyer, C. [1 ]
Lecomte, I. [1 ]
Avellino, V. [1 ]
Grateau, G. [1 ,2 ]
Girot, R. [2 ,3 ]
Lefevre, G. [4 ]
机构
[1] Hop Tenon, AP HP, Serv Med Interne, Ctr Reference Drepanocytose Adulte, F-75970 Paris 20, France
[2] Univ Paris 06, Fac Med, Paris, France
[3] Hop Tenon, AP HP, Serv Hematol Biol, Ctr Reference Drepanocytose Adulte, F-75970 Paris 20, France
[4] Hop Tenon, AP HP, Serv Biochim & Hormonol, F-75970 Paris 20, France
关键词
Sickle-cell anemia; Fever; Infection; Procalcitonin;
D O I
10.1007/s15010-010-0072-6
中图分类号
R51 [传染病];
学科分类号
100401 ;
摘要
Fever is often present during painful vaso-occlusive crisis (VOC) in sickle-cell disease (SCD), but does not always indicate infection. The aim of our study was to test procalcitonin as a marker of invasive bacterial infection in VOC. Consecutive SCD adults hospitalized for VOC were included. Data were collected at admission and within 24 h after the onset of fever. We distinguished patients with clinically defined and microbiologically documented invasive bacterial infection from patients with no evidence of invasive bacterial infection and who fared well without antibiotics. One hundred and twelve patients were enrolled (61% females, median age 23 years, 88% homozygous SCD). All patients with procalcitonin (PCT) level a parts per thousand yen1 mu g/L had an invasive bacterial infection, but two patients (33%) with an invasive bacterial infection had a PCT level < 1 mu g/L. High levels of PCT indicate invasive bacterial infection. However, a single low PCT level without follow-up measurement cannot rule out an invasive bacterial infection and should not withhold the prescription of antibiotics.
引用
收藏
页码:41 / 45
页数:5
相关论文
共 11 条
[1]   Discrimination of infectious and noninfectious causes of early acute respiratory distress syndrome by procalcitonin [J].
Brunkhorst, FM ;
Eberhard, OK ;
Brunkhorst, R .
CRITICAL CARE MEDICINE, 1999, 27 (10) :2172-2176
[2]  
GUYATT GH, 1986, CAN MED ASSOC J, V134, P587
[3]   Usefulness of procalcitonin as a marker of systemic infection in emergency department patients: A prospective study [J].
Hausfater, P ;
Garric, S ;
Ayed, SB ;
Rosenheim, M ;
Bernard, M ;
Riou, B .
CLINICAL INFECTIOUS DISEASES, 2002, 34 (07) :895-901
[4]   Procalcitonin in fever of unknown origin after liver transplantation:: A variable to differentiate acute rejection from infection [J].
Kuse, ER ;
Langefeld, I ;
Jaeger, K ;
Külpmann, WR .
CRITICAL CARE MEDICINE, 2000, 28 (02) :555-559
[5]   Pathobiochemistry and clinical use of procalcitonin [J].
Meisner, M .
CLINICA CHIMICA ACTA, 2002, 323 (1-2) :17-29
[6]   Procalcitonin is not produced by circulating blood cells [J].
Monneret, G ;
Laroche, B ;
Bienvenu, J .
INFECTION, 1999, 27 (01) :34-35
[7]   The potential role of procalcitonin and interleukin 8 in the prediction of infected necrosis in acute pancreatitis [J].
Rau, B ;
Steinbach, G ;
Gansauge, F ;
Mayer, JM ;
Grünert, A ;
Beger, HG .
GUT, 1997, 41 (06) :832-840
[8]   Evidence base of clinical diagnosis - The architecture of diagnostic research [J].
Sackett, DL ;
Haynes, RB .
BRITISH MEDICAL JOURNAL, 2002, 324 (7336) :539-541
[9]  
Scott L Keith, 2003, Med Sci Monit, V9, pCR426
[10]   Effect of Procalcitonin-Guided Treatment in Patients with Infections: a Systematic Review and Meta-Analysis [J].
Tang, H. ;
Huang, T. ;
Jing, J. ;
Shen, H. ;
Cui, W. .
INFECTION, 2009, 37 (06) :497-507